[Commentary on] Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification

E Galani; P A Ellis

[Commentary on] Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification

King's College London

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	177 - 178
Number of pages	2
Journal	Women's Oncology Review
Volume	2
Issue number	2
Publication status	Published - 2002

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{efd4f45c0dbf496d8f447487de8cb153,

title = "[Commentary on] Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification",

author = "E Galani and Ellis, {P A}",

year = "2002",

language = "English",

volume = "2",

pages = "177 -- 178",

journal = "Women's Oncology Review",

publisher = "Parthenon Publishing Group",

number = "2",

}